These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 16807456)

  • 21. Selecting new upfront regimens for advanced ovarian cancer with biomarker guidance.
    Chan JK; Liang SY; Kapp DS; Chan JE; Herzog TJ; Coleman RL; Monk BJ; Richardson MT
    Gynecol Oncol; 2020 Dec; 159(3):604-606. PubMed ID: 32994055
    [No Abstract]   [Full Text] [Related]  

  • 22. Treatment of gynecologic cancer: the US experience.
    Ozols R
    Tumori; 1999; 85(3 Suppl 1):S5-11. PubMed ID: 10542879
    [No Abstract]   [Full Text] [Related]  

  • 23. Advances in the understanding and treatment of ovarian cancer.
    Morrison J
    J Br Menopause Soc; 2005 Jun; 11(2):66-71. PubMed ID: 15970018
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does secondary surgical cytoreduction improve survival in women with advanced ovarian cancer?
    Munkarah A
    Nat Clin Pract Oncol; 2005 Apr; 2(4):188-9. PubMed ID: 16264930
    [No Abstract]   [Full Text] [Related]  

  • 25. [Standard of chemotherapy in ovarian cancer].
    Pfleiderer A; Meerpohl HG
    Chirurg; 1994 Jan; 65(1):18-22. PubMed ID: 8149794
    [No Abstract]   [Full Text] [Related]  

  • 26. Time to include high-risk early ovarian cancer in randomized phase III trials of advanced ovarian cancer.
    Vergote I; Amant F
    Gynecol Oncol; 2006 Sep; 102(3):415-7. PubMed ID: 16979430
    [No Abstract]   [Full Text] [Related]  

  • 27. Cytoreductive surgery and HIPEC in recurrent epithelial ovarian cancer: a prospective randomized phase III study.
    Spiliotis J; Halkia E; Lianos E; Kalantzi N; Grivas A; Efstathiou E; Giassas S
    Ann Surg Oncol; 2015 May; 22(5):1570-5. PubMed ID: 25391263
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of Ovarian Cancer In Younger Women.
    Uma Devi K; Purushotham N; Jayashree N
    Rev Recent Clin Trials; 2015; 10(4):263-9. PubMed ID: 26411956
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Adjuvant measures after primary surgery of ovarian cancer].
    Bauknecht T
    Gynakologe; 1994 Apr; 27(2):70-5. PubMed ID: 8039745
    [No Abstract]   [Full Text] [Related]  

  • 30. Prognostic factors and clinical outcome of patients with recurrent early-stage epithelial ovarian cancer: an Italian multicenter retrospective study.
    Gadducci A; Cosio S; Zola P; Sostegni B; Fuso L; Sartori E
    Int J Gynecol Cancer; 2013 Mar; 23(3):461-8. PubMed ID: 23370604
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ovarian cancer: a focus on management of recurrent disease.
    Herzog TJ; Pothuri B
    Nat Clin Pract Oncol; 2006 Nov; 3(11):604-11. PubMed ID: 17080178
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcome of recurrent and persistent disease of malignant ovarian germ cell tumor: a retrospective analysis at King Chulalongkorn Memorial Hospital.
    Lertkhachonsuk R; Manchana T; Termrungruanglert W; Vasuratna A; Sittisomwong T; Worasethsin P; Sirisabya N; Khemapech N; Tresukosol D
    J Med Assoc Thai; 2006 Feb; 89(2):138-44. PubMed ID: 16578998
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Ovarian carcinoma--diagnosis and treatment. Consensus conference of the National Institute of Health].
    Bornkessel B
    Med Monatsschr Pharm; 1995 Oct; 18(10):292-6. PubMed ID: 7476655
    [No Abstract]   [Full Text] [Related]  

  • 34. Low-Grade Serous Carcinoma of the Ovary.
    Grisham RN
    Oncology (Williston Park); 2016 Jul; 30(7):650-2. PubMed ID: 27422112
    [No Abstract]   [Full Text] [Related]  

  • 35. Treatment Outcomes of Epithelial Ovarian Cancers Following Maximum Cytoreduction and Adjuvant Paclitaxel-Carboplatin Chemotherapy: Egyptian NCI Experience.
    Nassar HR; Zeeneldin AA; Helal AM; Ismail YM; Elsayed AM; Elbassuiony MA; Moneer MM
    Asian Pac J Cancer Prev; 2015; 16(16):7237-42. PubMed ID: 26514517
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ESMO minimum clinical recommendations for diagnosis, treatment and follow-up of ovarian cancer.
    Ann Oncol; 2001 Sep; 12(9):1205-7. PubMed ID: 11697825
    [No Abstract]   [Full Text] [Related]  

  • 37. [Combined treatment of malignant ovarian tumors].
    Pereslegin IA; Zolotkov AG; Mikelova LV
    Vopr Onkol; 1989; 35(5):528-35. PubMed ID: 2662603
    [No Abstract]   [Full Text] [Related]  

  • 38. Management of early ovarian cancer.
    Young RC; Pecorelli S
    Semin Oncol; 1998 Jun; 25(3):335-9. PubMed ID: 9633845
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Five-year survival following combination radiotherapy and chemotherapy for recurrent mixed mesodermal sarcoma of the ovary.
    Carlson JA; Day TG
    Gynecol Oncol; 1985 Sep; 22(1):129-32. PubMed ID: 4018656
    [No Abstract]   [Full Text] [Related]  

  • 40. The role of hyperthermic intraperitoneal chemotherapy using paclitaxel in platinum-sensitive recurrent epithelial ovarian cancer patients with microscopic residual disease after cytoreduction.
    Cascales-Campos PA; Gil J; Feliciangeli E; Gil E; González-Gil A; López V; Ruiz-Pardo J; Nieto A; Parrilla JJ; Parrilla P
    Ann Surg Oncol; 2015 Mar; 22(3):987-93. PubMed ID: 25212832
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.